NCT02363478View on ClinicalTrials.gov

Long Term Effect of Buspirone on Esophageal Function and Esophageal Symptoms in Patients With Systematic Sclerosis (SSc)

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Systemic Sclerosis
Interventions
DRUG

buspirone

buspirone 10 mg X2 for 4 weeks

Trial Locations (1)

11527

Academic Department of Gastroenterology, Laikon GH, Athens

All Listed Sponsors
lead

Laikο General Hospital, Athens

OTHER

NCT02363478 - Long Term Effect of Buspirone on Esophageal Function and Esophageal Symptoms in Patients With Systematic Sclerosis (SSc) | Biotech Hunter | Biotech Hunter